Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.
ACOR Opens Cancer-pain.org
Connie Mack Joins Washington Office Of Shaw Pittman.
Richard Wood, ICRF, Accepts Appointment At Pittsburgh.
Cancer Groups In Campaign To Draft Pazdur For FDA.
NCI Seeks 150 Advocates For Advice On Plans, Policies.
“Harm-Reduction” Products No Proven, IOM Report Says.
MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.
FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.
Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.
Response Oncology Sells Practice Back To Physicians.
EntreMed Issued U.S. Patent For Active Parts Of Endostatin.
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”
